Ji Jing

11PUBLICATIONS
48CO-AUTHORS
Nanoscale characterisationMolecular targetsProteins and peptidesCancer geneticsChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 22, 2026
Nongenetic engineering nanozyme proximity labeling reveals subcellular in situ interactomes and trafficking pathways of nanoparticles.

|Jun 18, 2026
PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated Chemoresistance.

|Nov 24, 2025
FLASH-AWAY: Intrabody-Directed Targeting of Optogenetic Tools for Protein Degradation.

Zirui Zhuang, Ran Li, Bing Wang

|Dec 13, 2024
Prospects for PARG inhibitors in cancer therapy.

Yangchan Hu, Yuxin Meng, Zirui Zhuang

|Nov 14, 2023
Advancements and Obstacles of PARP Inhibitors in Gastric Cancer.

Hongjie Chen, Yangchan Hu, Zirui Zhuang

|May 10, 2023
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer.

Ziyan Yang, Jianguo Feng, Ji Jing

Pageof 2

Frequent Collaborators

5 joint publications

Yubin Zhou

2 joint publications

Yun Huang

2 joint publications

Zirui Zhuang

2 joint publications

Yangchan Hu